Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 27;72(2):249-253.
doi: 10.1093/cid/ciaa849.

Estimation of SARS-CoV-2 Infection Fatality Rate by Real-time Antibody Screening of Blood Donors

Affiliations

Estimation of SARS-CoV-2 Infection Fatality Rate by Real-time Antibody Screening of Blood Donors

Christian Erikstrup et al. Clin Infect Dis. .

Abstract

Background: The pandemic due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has tremendous consequences for our societies. Knowledge of the seroprevalence of SARS-CoV-2 is needed to accurately monitor the spread of the epidemic and to calculate the infection fatality rate (IFR). These measures may help the authorities make informed decisions and adjust the current societal interventions. The objective was to perform nationwide real-time seroprevalence surveying among blood donors as a tool to estimate previous SARS-CoV-2 infections and the population-based IFR.

Methods: Danish blood donors aged 17-69 years giving blood 6 April to 3 May were tested for SARS-CoV-2 immunoglobulin M and G antibodies using a commercial lateral flow test. Antibody status was compared between geographical areas, and an estimate of the IFR was calculated. Seroprevalence was adjusted for assay sensitivity and specificity taking the uncertainties of the test validation into account when reporting the 95% confidence intervals (CIs).

Results: The first 20 640 blood donors were tested, and a combined adjusted seroprevalence of 1.9% (95% CI, .8-2.3) was calculated. The seroprevalence differed across areas. Using available data on fatalities and population numbers, a combined IFR in patients <70 years is estimated at 89 per 100 000 (95% CI, 72-211) infections.

Conclusions: The IFR was estimated to be slightly lower than previously reported from other countries not using seroprevalence data. The IFR is likely severalfold lower than the current estimate. We have initiated real-time nationwide anti-SARS-CoV-2 seroprevalence surveying of blood donations as a tool in monitoring the epidemic.

Keywords: COVID-19; SARS-CoV-2; emerging infectious disease; epidemic monitoring; seroprevalence.

PubMed Disclaimer

Comment in

References

    1. Ruan S. Likelihood of survival of coronavirus disease 2019. Lancet Infect Dis 2020. Available at: http://www.sciencedirect.com/science/article/pii/S1473309920302577. Accessed 12 April 2020. - PMC - PubMed
    1. Årsberetning for Bloddonorerne i Danmark 2018–2019. Available at: https://forening.bloddonor.dk/wp-content/uploads/2019/06/BiD-Aarsberetni.... Accessed 15 April 2020.
    1. Ullum H, Rostgaard K, Kamper-Jørgensen M, et al. Blood donation and blood donor mortality after adjustment for a healthy donor effect. Transfusion 2015; 55:2479–85. - PubMed
    1. Danish Prime Minister Press Conferences, Spring 2020—transcripts in Danish. Available at: https://www.stm.dk/_p_12743.html. Accessed 10 June 2020.
    1. Statistics Denmark. Population data. Available at: https://www.statistikbanken.dk/statbank5a/default.asp?w=1440. Accessed 14 April 2020.

Substances